MCM
NVO

Mattern Capital Management’s Novo Nordisk NVO Stock Holding History

Mattern Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
41,849
-4,475
-10% -$192K 0.23% 88
2026
Q1 		$1.7M Buy
46,324
+16,524
+55% +$783K 0.2% 94
2025
Q4 		$1.52M Buy
29,800
+10,019
+51% +$512K 0.18% 99
2025
Q3 		$1.1M Buy
19,781
+6,654
+51% +$389K 0.13% 114
2025
Q2 		$906K Buy
13,127
+4,784
+57% +$325K 0.11% 114
2025
Q1 		$579K Buy
8,343
+4,526
+119% +$374K 0.07% 124
2024
Q4 		$328K Buy
+3,817
New +$413K 0.04% 140

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mattern Capital Management's NVO Position: Q2 2026 in Review

Mattern Capital Management reduced its Novo Nordisk (NVO) stake by 9.7% in Q2 2026, selling an estimated $192K and leaving 41,849 shares worth $2.01M. The position accounts for 0.23% of the portfolio, ranked #88.

Mattern Capital Management first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mattern Capital Management held 41,849 shares of Novo Nordisk worth $2.01M as of Q2 2026.
  • Mattern Capital Management sold 4,475 Novo Nordisk shares in Q2 2026, an estimated $192K.
  • Novo Nordisk made up 0.23% of Mattern Capital Management's portfolio in Q2 2026, its #88 holding.
  • Mattern Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mattern Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.